(Q34463933)

2 August 2017

1 reference

title

Cutaneous melanoma: prognostic factors (English)

1 reference

2 August 2017

Adil Daud

4

1 reference

ORCID Public Data File 2021

author name string

Jade Homsi

series ordinal

1

1 reference

2 August 2017

Mohammed Kashani-Sabet

series ordinal

2

1 reference

2 August 2017

Jane L Messina

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

2 August 2017

1 reference

2 August 2017

12

1 reference

2 August 2017

4

1 reference

2 August 2017

223-229

1 reference

2 August 2017

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

A new American Joint Committee on Cancer staging system for cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Cutaneous melanoma: prognosis and treatment results worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Melanoma in the Elderly Patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Age as a prognostic factor in the malignant melanoma population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Lethal "thin" malignant melanoma. Identifying patients at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Predicting survival and recurrence in localized melanoma: a multivariate approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Model predicting survival in stage I melanoma based on tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

The prognostic significance of ulceration of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

An evidence-based staging system for cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Tumor vascularity in the prognostic assessment of primary cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

NF-kappa B in the vascular progression of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Prognostic factors in primary cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (> 5 mm).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Prognosis in patients with thin malignant melanoma: influence of regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

V599EB-RAF is an oncogene in melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

The Brn-2 transcription factor links activated BRAF to melanoma proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Guilty as charged: B-RAF is a human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

High frequency of BRAF mutations in nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

Microarray expression profiling in melanoma reveals a BRAF mutation signature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480501200403

10.1177/107327480501200403

21 January 2018

Identifiers

DOI

0 references

1 reference